| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 03/25/1992 | EP0476875A2 Process for the purification and concentration of biologically active materials |
| 03/25/1992 | EP0476515A1 New amino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same |
| 03/24/1992 | US5098996 Process for introducing fluorine into biologically active materials |
| 03/24/1992 | US5098924 Hypotensive agents and angiotensin II inhibitors |
| 03/24/1992 | US5098892 Angiotensin converting enzyme inhibitors as hypotensive agents |
| 03/24/1992 | US5098888 Cholinergic agents and antispasmodic agents |
| 03/24/1992 | US5098841 Process for the preparation of hydroxy acids |
| 03/24/1992 | US5098828 Immunoassay and testing |
| 03/24/1992 | CA1298035C Antitumor amino acid and peptide derivatives of 1,4- bis¬(aminoalkyl andhydroxyaminoalkyl)amino|-5, 8-dihydroxyanthraquinones |
| 03/24/1992 | CA1298034C Amino acid derivatives |
| 03/24/1992 | CA1298033C Dipeptide derivative of fatty acid |
| 03/19/1992 | WO1992004446A1 Cloning of chicken anaemia dna |
| 03/19/1992 | WO1992004370A1 Modified di- and tripeptidyl immunosuppressive compounds |
| 03/19/1992 | WO1992004320A1 N-SUBSTITUTED CYCLOALKYL AND POLYCYCLOALKYL ALPHA-SUBSTITUTED Trp DERIVATIVES |
| 03/19/1992 | WO1992004045A1 Novel cholecystokinin antagonists, their preparation and therapeutic use |
| 03/19/1992 | WO1992004038A1 Pro-drugs for cck antagonists |
| 03/19/1992 | CA2088195A1 Cholecystokinin antagonists, their preparation and therapeutic use |
| 03/18/1992 | CA2051455A1 Amino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same |
| 03/17/1992 | US5097060 Adjusting the initial concentration and cooling through conductive heat transfer without forced flow |
| 03/17/1992 | US5097014 Chromogenic tripeptides |
| 03/17/1992 | US5096884 Glidobactin pf-1 peptide antibiotics |
| 03/17/1992 | CA1297633C Phenylalanine derivative and proteinase inhibitor |
| 03/17/1992 | CA1297632C Organic compounds and their pharmaceutical use |
| 03/17/1992 | CA1297631C Ureido renin inhibitors |
| 03/13/1992 | WO1992004369A1 5-aminosalicylic acid derivatives for the therapy of chronic inflammatory bowel diseases |
| 03/13/1992 | CA2091459A1 5-aminosalicylic acid derivatives for the therapy of chronic inflammatory bowel diseases |
| 03/13/1992 | CA2051157A1 Neurotrophic peptide derivatives |
| 03/11/1992 | EP0474553A1 Actinonin derivatives |
| 03/11/1992 | EP0474456A2 Oligopeptides exhibiting selective inhibiting effect upon the proliferation of hemopoietic cells |
| 03/11/1992 | EP0474414A1 High purity crystalline forms of peptides Arg-Lys-Asp and Arg-Lys-Asp-Val, process for preparing them and pharmaceutical compositions containing them |
| 03/11/1992 | EP0474008A1 Amino acid derivatives |
| 03/11/1992 | EP0473993A2 Novel peptide derivatives and their pharmaceutical use |
| 03/11/1992 | EP0473936A1 Renin Inhibitors |
| 03/10/1992 | US5095139 Fungicides |
| 03/10/1992 | US5095093 Protective four amino acid epitope against Plasmodium vivax malaria |
| 03/10/1992 | US5095006 Renin inhibitors having all retro-inverted peptide bonds |
| 03/08/1992 | WO1992004371A1 Kininogenase inhibitors |
| 03/08/1992 | CA2090858A1 Kininogenase inhibitors |
| 03/05/1992 | WO1992003472A1 Peptides containing amino-polyols as transition-state mimics |
| 03/05/1992 | WO1992003147A1 Peptides that block human immunodeficiency virus infections and methods of use thereof |
| 03/05/1992 | CA2050434A1 Renin inhibitors |
| 03/04/1992 | EP0472670A1 Symmetrical bipeptides including a polyalkylene-gylcol group, method of preparation and use in protease determination. |
| 03/03/1992 | US5093478 Esterification of glutathione with alcohol, neutralization with ion exchange resin |
| 03/03/1992 | US5093320 Immunosuppressants |
| 03/03/1992 | US5093243 Process for the separation and recovery of nosiheptide |
| 03/01/1992 | CA2050092A1 Amino acid derivatives |
| 02/27/1992 | DE4026703A1 New hydroxyethyl-amine and norstatin-type pseudo:peptide(s) |
| 02/26/1992 | EP0472078A2 Phosphonopyrrolidin- and piperidin-containing statin-type pseudopeptides, their preparation and use against retroviruses |
| 02/26/1992 | EP0472077A2 Phosphonate containing hydroxyethylamin- and norstatin-type pseudopeptides |
| 02/26/1992 | EP0471833A1 Method for increasing the alpha to beta ratio in an aspartame coupling reaction. |
| 02/26/1992 | CN1058971A One-pot-process for preparation of a-l-aspartyl-l-phenylalanine methyl ester hydrochloride |
| 02/25/1992 | US5091575 Peptidylaminodiols |
| 02/25/1992 | US5091510 Retro-inverso analogues of thymopentin, and their use in the preparation of pharmaceutical compositions |
| 02/25/1992 | US5091427 Cognition activators |
| 02/25/1992 | US5091396 Pyridyl peptide mimetic compounds which are useful platelet-aggregation inhibitors |
| 02/25/1992 | US5091375 Nikkomycin derivatives |
| 02/25/1992 | US5091368 Biologically active compounds from blue-green algae |
| 02/25/1992 | CA2049645A1 Phosphonate-containing pseudopeptides of the hydroxyethylamine and norstatin type |
| 02/24/1992 | CA2049497A1 Phosphonopyrrolidine-and piperidine-containing pseudopeptides of the statin type, a process for their preparation and their use as medicaments against retroviruses |
| 02/20/1992 | WO1992002541A1 Biologically active compounds from blue-green algae |
| 02/19/1992 | EP0471651A2 Peptide boronic acid derivatives having protease inhibiting activity |
| 02/19/1992 | EP0471280A2 Trans-2-acylaminocyclohexyloxyacyldipeptides |
| 02/19/1992 | EP0471028A1 Highly cytopathogenic hiv-ndk retrovirus, dna fragments of this retrovirus, method for preparing a protein and/or an enzyme of this virus, and the applications of these |
| 02/19/1992 | CN1058783A Process for preparation of alpha-l-aspartyl-l-phenylalanine methyl ester hydrochloride by use of isolated n-formyl l-aspartic anhydride |
| 02/18/1992 | US5089638 Amino acid analogs as CCK-antagonists |
| 02/18/1992 | US5089616 From 3-(2-amino-4-thiazolyl)-L-alanine, without protection of the aminothiazole group |
| 02/18/1992 | US5089492 Pharmaceuticals and dietetics containing acylamino acid derivatives |
| 02/18/1992 | US5089476 Glutamic acid derivatives |
| 02/18/1992 | CA2049390A1 Novel peptide derivatives and their pharmaceutical use |
| 02/14/1992 | CA2048953A1 Borolysine peptidomimetics |
| 02/12/1992 | EP0470175A1 Enzymatic membrane method for the synthesis and separation of peptides |
| 02/11/1992 | US5087618 Antiviral, anticancer, antitumor agents |
| 02/11/1992 | US5087614 Inhibits aspartic proteinases |
| 02/11/1992 | CA1295785C Process for the preparation of aspartame and agents for carrying it out |
| 02/11/1992 | CA1295784C Peptide immunostimulants |
| 02/11/1992 | CA1295624C Process for the manufacture of novel guanidinium aspartates |
| 02/06/1992 | WO1992001708A1 Vinylsulphonyl pristinamycin and preparation thereof |
| 02/06/1992 | WO1992001694A1 New salts derived from dialkylaminoalkylsulphonyl-26 pristinamycin ii¿b? |
| 02/06/1992 | WO1992001692A1 Method for preparing sulphonylpristinamycin ii¿b? |
| 02/06/1992 | WO1992001468A1 Endoserine converting enzyme inhibitor or vascular twitch remedy |
| 02/06/1992 | CA2086923A1 Vinylsulphonyl pristinamycin and preparation thereof |
| 02/05/1992 | EP0469156A1 Glutathione derivative |
| 02/05/1992 | EP0468998A1 Peptides having novel polar n-terminal groups |
| 02/04/1992 | WO1992002617A1 Use of crosslinked crystals as a novel form of enzyme immobilization |
| 02/04/1992 | US5086165 Inhibitors of retroviral protease with a ketomethylene isosteric replaced amide bond |
| 02/04/1992 | US5086069 Anti-thrombotic peptide and pseudopeptide derivatives |
| 01/29/1992 | EP0468946A1 Enzymatic method of determining beta-lactam ring antibiotics |
| 01/29/1992 | EP0468641A2 Renin inhibiting dipeptide derivatives, their preparation and pharmaceutical preparations containing them |
| 01/29/1992 | EP0468339A2 Alpha-keto-amide derivatives having protease inhibiting activity |
| 01/29/1992 | EP0468063A1 A one-pot process for the preparation of alpha-L-aspartyl-L-phenylalanine methyl ester hydrochloride |
| 01/28/1992 | US5084444 Anticoagulants and enzyme inhibitors |
| 01/28/1992 | CA1295086C 4-aminobutanoic acid derivatives, process of preparation and usethereof |
| 01/28/1992 | CA1295085C Heptanoyl-glu-asp-ala-amino acid immunostimulants |
| 01/25/1992 | WO1992001709A1 Process for synthesizing peptides |
| 01/25/1992 | CA2086416A1 Process for synthesizing peptides |
| 01/23/1992 | WO1992000956A1 Inhibitors of aspartic proteases |
| 01/23/1992 | WO1992000954A1 Aspartic protease inhibitors |
| 01/23/1992 | WO1992000953A1 A one-pot process for the preparation of alpha-l-aspartyl-l-phenylalanine methyl ester hydrochloride |
| 01/23/1992 | WO1992000950A1 A process for the preparation of alpha-l-aspartyl-l-phenylalanine methyl ester hydrochloride by use of isolated n-formyl l-aspartic anhydride |
| 01/23/1992 | WO1992000948A1 Inhibitors of retroviral proteases |